ABCNEWS - Allergy med recalled for potential cross-contamination
An allergy medication has been recalled for potential cross-contamination with ranitidine.
An allergy medication has been recalled for potential cross-contamination with ranitidine.
Fast Acting Max Strength
The recall is classified as Class III, the FDA’s lowest risk level, meaning it's "not likely to cause adverse health consequences."
The recalled pods, labeled as decaf, may contain caffeine.
AI:More than 80,000 Keurig coffee pods are being recalled due to a labeling error; pods marked as decaf may actually contain caffeine.Open